Background—Patients with diabetes have more extensive coronary disease than those
without diabetes, resulting in more challenging percutaneous coronary intervention or …

Background—The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial assigned patients with type 2 diabetes mellitus to prompt coronary revascularization …

Background—In the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial, an initial strategy of coronary revascularization and optimal medical treatment …

A paradoxical increase in mortality attributable to diabetes has occurred, particularly during
the last decade, despite the overall decrease in mortality attributable to coronary artery …

This report describes the baseline angiographic findings in the Bypass Angioplasty
Revascularization Investigation (BARI) 2 Diabetes (BARI 2D) trial, a randomized study that …

Modern coronary revascularization therapies, coronary artery bypass graft (CABG) surgery
and percutaneous coronary intervention (PCI), continue to evolve and are widely applied …

BACKGROUND: The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial was undertaken to determine whether early revascularization intervention is …

Objectives: We evaluated demographic, clinical, and angiographic factors influencing the
selection of coronary artery bypass graft (CABG) surgery versus percutaneous coronary …

(T2DM), accounting for two thirds of patient deaths. In addition to traditional cardiovascular
risk factors, hyperglycemia and multiple other factors associated with T2DM such as obesity …

Background: It is unknown if coronary artery bypass grafting (CABG) or percutaneous
coronary intervention (PCI) may offer a survival benefit in patients with type 1 diabetes (T1D) …